Dr James Wilmott wins 2020 Wildfire Highly Cited Publication Award
24 November 2020
Congratulations to Dr James Wilmott and everyone involved in this important work, which today won the 2020 Wildfire Highly Cited Publication Award.
“Our research really highlighted that melanoma is not one large cancer type. It’s actually made up of different molecular phenotypes relating to where the melanoma originates,” Dr James Wilmott
Whole-genome landscapes of major melanoma subtypes was published in 2017 in Nature, an international journal featuring peer-reviewed research in scientific technology. The project was led by Dr James Wilmott and is a collaboration across Melanoma Institute Australia (MIA), QIMR Berghofer Medical Research Institute, and The University of Sydney, and had about 50 co-authors.
Tissue samples from 183 Australian patients were sourced from biobanks, including the MIA and Peter MacCallum Cancer Centre in Victoria.
This vital study will help improve outcomes for people with melanoma. It has been cited an amazing 362 times around the world since it was published.
Dr Wilmott and his team have received international recognition for their research in the clinical implications of genomic profiling, and the progress they have made so far keeps them motivated.
“We will keep working on finding cures for melanoma patients.” Dr James Wilmott
Find out more about the study and how it came together: Cancer Institute NSW Wildfire Highly Cited Publication Award background
Sydney Health Partners' goal is to ensure world class research is successfully implemented & scaled-up to benefit patients & wider society.
Promising young MIA researcher conferred with University of Sydney PhD.
Jana Pittman and Melinda Gainsford-Taylor urge Australians to be sun-safe and check their skin as they join the Game On Mole campaign in support of their much-loved coach
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
Honouring the exceptional impact of his work on communities around the world.
MIA's Co-Medical Directors receive University of Sydney's Vice-Chancellor's Award for Outstanding Research
Awarded for their life-saving discoveries transforming melanoma patient care.
National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment
Recognising her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
Clinicians and researchers from across Australia and beyond united online, bringing the AMC2021 conference theme of Promising Futures to life.
Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.
MIA is proud to announce that five of our researchers have been named on the Clarivate Annual Highly Cited Researchers™ 2021 list.
New research shows routine skin checks by a health professional, coupled with checking your own skin, are vital in saving lives from melanoma.
With new patient figures indicating people may have deferred skin checks during the pandemic our Game On Mole campaign is more important than ever.
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Read more about the wonderful MIA community fundraising initiatives held recently.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.